The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative

Previous study demonstrated that Ganoderma meroterpene derivative (GMD) increased the abundance of butyrate-producing bacteria in gut and subsequently delivered anti-metabolic disorder effect of host. To specify the key commensal bacteria associating with the beneficial effects, we tried to isolate...

Full description

Saved in:
Bibliographic Details
Main Authors: Shanshan Qiao, Kai Wang, Chang Liu, Nan Zhou, Li Bao, Jun Wang, Shuangjiang Liu, Hongwei Liu
Format: Article
Language:English
Published: Tsinghua University Press 2022-01-01
Series:Food Science and Human Wellness
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213453021000768
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557773950287872
author Shanshan Qiao
Kai Wang
Chang Liu
Nan Zhou
Li Bao
Jun Wang
Shuangjiang Liu
Hongwei Liu
author_facet Shanshan Qiao
Kai Wang
Chang Liu
Nan Zhou
Li Bao
Jun Wang
Shuangjiang Liu
Hongwei Liu
author_sort Shanshan Qiao
collection DOAJ
description Previous study demonstrated that Ganoderma meroterpene derivative (GMD) increased the abundance of butyrate-producing bacteria in gut and subsequently delivered anti-metabolic disorder effect of host. To specify the key commensal bacteria associating with the beneficial effects, we tried to isolate and compare the microbiota from the cecal samples of GMD- and vehicle-treated ob/ob mice, and further identified butyrate-producing bacterial strains. It was found that Faeciroseburia intestinalis was enriched and 11 strains affiliated to F. intestinalis were cultivated from the gut of GMD-treated mice. In vitro assay attested butyrate production by representative strain of F. intestinalis. Oral administration with F. intestinalis further demonstrated its benefits on regulating hyperglycemia and hyperlipidemia, on decreasing plasma lipopolysaccharide (LPS) and inflammation, and on improving hepatic injuries. Treatment with F. intestinalis effectively enhanced the level of gut butyrate, which subsequently ameliorated the intestinal barrier function and activated epithelial PPAR-γ signaling pathway to regulate microbiome homeostasis in gut. Our study demonstrated that the causal relationship between the butyrate-producing bacteria and the GMD's therapeutic effects and confirmed the important function of the butyrate-producing F. intestinalis in maintaining host metabolism homeostasis.
format Article
id doaj-art-7379e9a02edf4f70baaba38525405d77
institution Kabale University
issn 2213-4530
language English
publishDate 2022-01-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-7379e9a02edf4f70baaba38525405d772025-02-03T02:39:17ZengTsinghua University PressFood Science and Human Wellness2213-45302022-01-011118596The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivativeShanshan Qiao0Kai Wang1Chang Liu2Nan Zhou3Li Bao4Jun Wang5Shuangjiang Liu6Hongwei Liu7State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Microbial Technology, Shandong University, Tsingdao 266237, Shandong, China; State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Shijitan Hospital, Capital Medicinal University, Beijing 100038, ChinaCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Microbial Technology, Shandong University, Tsingdao 266237, Shandong, China; State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; Corresponding authors at: Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China; Corresponding authors at: Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.Previous study demonstrated that Ganoderma meroterpene derivative (GMD) increased the abundance of butyrate-producing bacteria in gut and subsequently delivered anti-metabolic disorder effect of host. To specify the key commensal bacteria associating with the beneficial effects, we tried to isolate and compare the microbiota from the cecal samples of GMD- and vehicle-treated ob/ob mice, and further identified butyrate-producing bacterial strains. It was found that Faeciroseburia intestinalis was enriched and 11 strains affiliated to F. intestinalis were cultivated from the gut of GMD-treated mice. In vitro assay attested butyrate production by representative strain of F. intestinalis. Oral administration with F. intestinalis further demonstrated its benefits on regulating hyperglycemia and hyperlipidemia, on decreasing plasma lipopolysaccharide (LPS) and inflammation, and on improving hepatic injuries. Treatment with F. intestinalis effectively enhanced the level of gut butyrate, which subsequently ameliorated the intestinal barrier function and activated epithelial PPAR-γ signaling pathway to regulate microbiome homeostasis in gut. Our study demonstrated that the causal relationship between the butyrate-producing bacteria and the GMD's therapeutic effects and confirmed the important function of the butyrate-producing F. intestinalis in maintaining host metabolism homeostasis.http://www.sciencedirect.com/science/article/pii/S2213453021000768Faeciroseburia intestinalisGanoderma meroditerpene derivativeGut microbiomeButyrateHypoglycemiaHypolipidemia
spellingShingle Shanshan Qiao
Kai Wang
Chang Liu
Nan Zhou
Li Bao
Jun Wang
Shuangjiang Liu
Hongwei Liu
The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative
Food Science and Human Wellness
Faeciroseburia intestinalis
Ganoderma meroditerpene derivative
Gut microbiome
Butyrate
Hypoglycemia
Hypolipidemia
title The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative
title_full The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative
title_fullStr The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative
title_full_unstemmed The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative
title_short The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative
title_sort enriched gut commensal faeciroseburia intestinalis contributes to the anti metabolic disorders effects of the ganoderma meroterpene derivative
topic Faeciroseburia intestinalis
Ganoderma meroditerpene derivative
Gut microbiome
Butyrate
Hypoglycemia
Hypolipidemia
url http://www.sciencedirect.com/science/article/pii/S2213453021000768
work_keys_str_mv AT shanshanqiao theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT kaiwang theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT changliu theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT nanzhou theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT libao theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT junwang theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT shuangjiangliu theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT hongweiliu theenrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT shanshanqiao enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT kaiwang enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT changliu enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT nanzhou enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT libao enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT junwang enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT shuangjiangliu enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative
AT hongweiliu enrichedgutcommensalfaeciroseburiaintestinaliscontributestotheantimetabolicdisorderseffectsoftheganodermameroterpenederivative